Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
LetterLetter

Complement C5-blocking Agent in Refractory Dermatomyositis

STANISLAS FAGUER, JULIE BELLIERE and DAVID RIBES
The Journal of Rheumatology December 2018, 45 (12) 1710-1711; DOI: https://doi.org/10.3899/jrheum.180060
STANISLAS FAGUER
Département de Néphrologie et Transplantation d’organes, and Centre de référence des maladies rénales rares, Centre Hospitalier de Toulouse;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for STANISLAS FAGUER
  • For correspondence: faguer.s{at}chu-toulouse.fr
JULIE BELLIERE
Département de Néphrologie et Transplantation d’organes, and Centre de référence des maladies rénales rares, Centre Hospitalier de Toulouse;
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAVID RIBES
Département de Néphrologie et Transplantation d’organes, and Centre de référence des maladies rénales rares, Centre Hospitalier de Toulouse.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Figures & Data

Figures

  • A and B. Severe acrocyanosis of the fingers and toes, with Gottron papules and scleroderma. C. Kinetics of CPK (red; IU/l), myoglobin (green; ng/ml), and troponin (blue, ng/l). IVIg: intravenous immunoglobulins; CPK: creatine phosphokinase; PEx: plasma exchange.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    A and B. Severe acrocyanosis of the fingers and toes, with Gottron papules and scleroderma. C. Kinetics of CPK (red; IU/l), myoglobin (green; ng/ml), and troponin (blue, ng/l). IVIg: intravenous immunoglobulins; CPK: creatine phosphokinase; PEx: plasma exchange.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 45, Issue 12
1 Dec 2018
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Complement C5-blocking Agent in Refractory Dermatomyositis
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Complement C5-blocking Agent in Refractory Dermatomyositis
STANISLAS FAGUER, JULIE BELLIERE, DAVID RIBES
The Journal of Rheumatology Dec 2018, 45 (12) 1710-1711; DOI: 10.3899/jrheum.180060

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Complement C5-blocking Agent in Refractory Dermatomyositis
STANISLAS FAGUER, JULIE BELLIERE, DAVID RIBES
The Journal of Rheumatology Dec 2018, 45 (12) 1710-1711; DOI: 10.3899/jrheum.180060
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • To the Editor:
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Juvenile Arthritis Quality of Life Questionnaire Responder Metrics in Juvenile Idiopathic Arthritis: Clarifying Health-Related Quality of Life Changes Across Treatment Eras
  • Dr. Tsai et al reply
  • If Treat-to-Target Works for Gout, Who Will Implement It in Primary Care?
Show more Letter

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire